Page 298 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Fatty Liver Disease: Clinical (Cont.)

P1023 QUANTIFICATION OF LIVER, PANCREAS, KIDNEY AND
VERTEBRAL BODY MRI-PDFF IN NONALCOHOLIC FATTY
LIVER DISEASE
Ilkay S. Idilman, Ali Tuzun, Berna Savas, Ramazan Idilman*,
Musturay Karcaaltincaba, Turkey

P1024 POPULATION, PRESCRIPTION AND EFFECTIVENESS
OF ADOMET TREATMENT FOR INTRAHEPATIC
CHOLESTASIS IN CHRONIC LIVER DISEASE DUE TO NON
ALCOHOLIC LIVER DISEASE (IHC IN NALD) IN THREE
POST MARKETING SURVEILLANCE STUDIES IN RUSSIA,
UKRAINE AND INDIA
Mario Ouwens, Suntje Sander-Struckmeier*, Julian Platon, Germany

P1025 INCREASING BURDEN OF NASH/CRYPTOGENIC
CIRRHOSIS IN CONTRIBUTION TO END-STAGE LIVER
COMPLICATIONS IN ASIA-PACIFIC
Wai Mun Loo*, Seng Gee Lim, Krishnakumar Madhavan,
Maureen Da Costa,Yock Young Dan, Singapore

ePOSTERS P1026 THE EVALUATION OF NON-ALCOHOLIC FATTY LIVER
DISEASE (NAFLD) AND ITS ASSOCIATE FACTORS IN
PSORIASIS PATIENTS USING ULTRASONOGRAPHY AND
THE CONTROLLED ATTENUATION PARAMETER (CAP)
MEASURED WITH TRANSIENT ELASTOGRAPHY
Abhasnee Sobhonslidsuk*, Jamrus Pongpit, Ammarin Thakkinstian,
Saneerat Porntharukchareon, Piyaporn Kaewdoung,
Kwannapa Promson, Wasana Stitchantrakul, Duangporn Saengwimol,
Supanna Petraksa, Natta Rajatanavin, Thailand

P1027 DO LEPTIN PROFILE AND INSULIN RESISTANCE FAVOR
OXIDATIVE STRESS AND DISEASE SEVERITY IN NON-
ALCOHOLIC FATTY LIVER DISEASE?
Billur Canbakan*, Hakan Senturk, Ibrahim Hatemi, Emine Koroglu,
Murat Tuncer, Kadri Atay, Nuray Kepil, Turkey

298 The International Liver Congress™ 2015 • ILC Programme